Share |

PrintPrintable version



Glaxo Shares Under Fire As $400 MM Lawsuit Looms

|

Glaxo Shares Under Fire As $400 MM Lawsuit Looms
By Mickey Clark
06/04/04 12:05 AM PT
Source: E-commerce Times

Spitzer accuses GSK of assuring doctors that the drug was safe for children to take while withholding research that indicated it was ineffective and in some case could lead to depression and even suicide. Early estimates say Glaxo's potential liability relating to Paxil could be almost US$400 million.

GlaxoSmithKline came under early selling pressure toda  after it emerged that New York Attorney General Ellio  Spitzer had filed a lawsuit accusing the drugs giant o  fraud and endangering the lives of children

The action focuses on the group's antidepressant Paxil, which has been cleared by the Food and Drug Administration for use by adults in the US and generates profits of around US$55 million a year for the company. Spitzer accuses GSK of assuring doctors that the drug was safe for children to take while withholding research that indicated it was ineffective and in some case could lead to depression and even suicide. Early estimates say Glaxo's potential liability relating to Paxil could be almost $400 million.
In the US, doctors are allowed to prescribe some adult-approved drugs to children so long as the company supplies accurate information to prove it is safe and effective.

Glaxo says it has not seen the writ but insists it has acted responsibly in conducting clinical studies with children. It intends to fight the claims.



  • Currently 0/5
  • 1
  • 2
  • 3
  • 4
  • 5
Rating: 0/5 (0 votes cast)




Health Supreme News

Loading...
‚Äč
Powered by Movable Type 5.13-en

Receive updates

Subscribe to get updates of this site by email:

Enter your Email


Preview | Powered by FeedBlitz

Other sites of ours